Edition:
United States

LeMaitre Vascular Inc (LMAT.OQ)

LMAT.OQ on NASDAQ Stock Exchange Global Market

32.67USD
3:59pm EST
Change (% chg)

$0.41 (+1.27%)
Prev Close
$32.26
Open
$32.32
Day's High
$32.84
Day's Low
$32.12
Volume
45,139
Avg. Vol
65,028
52-wk High
$39.88
52-wk Low
$19.83

Latest Key Developments (Source: Significant Developments)

Lemaitre Vascular sees ‍Q4 sales of $25.8 mln
Thursday, 26 Oct 2017 04:05pm EDT 

Oct 26 (Reuters) - Lemaitre Vascular Inc :Lemaitre Vascular Inc - qtrly earnings per share ‍$0.25​.Lemaitre Vascular Inc - qtrly ‍sales of $24.8 million, up 7% from Q3 2016​.Lemaitre Vascular Inc - sees ‍Q4 2017 sales of$25.8 million​.Lemaitre Vascular Inc - sees ‍Q4 EPS in range of $0.19 to $0.21​.Lemaitre Vascular Inc - sees ‍full year 2017 EPS in range of $0.83 to $0.85​.  Full Article

Lemaitre sees 2017 earnings per diluted share $0.79
Thursday, 27 Jul 2017 04:05pm EDT 

July 27 (Reuters) - Lemaitre Vascular Inc :Lemaitre Q2 2017 record sales $25.8 mm (+15%), record EPS $0.23 (+69%).Lemaitre Vascular Inc sees Q3 2017 sales $25.4 million (+10% reported, +3% organic).Lemaitre Vascular Inc sees 2017 sales $101.9 million; up 14% reported, up 8% organic.Lemaitre Vascular Inc sees 2017 earnings per diluted share $0.79.Lemaitre Vascular Inc sees Q3 2017 earnings per diluted share $0.20.Q2 earnings per share view $0.17, revenue view $25.4 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $0.18, revenue view $25.0 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $0.70, revenue view $100.6 million -- Thomson Reuters I/B/E/S.Lemaitre Vascular Inc sees Q3 2017 gross margin 70.0 percent, sees 2017 gross margin 70.0 percent.Lemaitre Vascular Inc - on July 25, 2017, company's board of directors authorized repurchase of up to $7.5 mm of company's common stock.  Full Article

Lemaitre Vascular says expects preliminary unaudited Q2 2017 sales to be in range of $25.4 mln-$25.7 mln
Friday, 7 Jul 2017 04:23pm EDT 

July 7 (Reuters) - Lemaitre Vascular Inc ::Says expects preliminary unaudited q2 2017 sales to be in range of $25.4 million to $25.7 million - sec filing.Q2 revenue view $25.4 million -- Thomson Reuters I/B/E/S.  Full Article

LeMaitre Vascular Inc Q1 earnings per share $0.16
Wednesday, 26 Apr 2017 04:05pm EDT 

April 26 (Reuters) - LeMaitre Vascular Inc ::LeMaitre Q1 2017 record sales $24.1 mm (+19%), net income $3.2 mm (+49%).Q1 earnings per share $0.16.Qtrly sales of $24.1 million up 19% versus. Q1 2016.Sees Q2 sales $25.4 million; sees Q2 earnings per share $0.17.Sees FY 2017 sales $100.5 million; sees FY earnings per share $0.70 .Q1 earnings per share view $0.13, revenue view $23.5 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.17, revenue view $25.0 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $0.66, revenue view $99.0 million -- Thomson Reuters I/B/E/S.  Full Article

Lemaitre sees q2 earnings per share $0.70
Wednesday, 26 Apr 2017 04:05pm EDT 

April 26 (Reuters) - Lemaitre Vascular Inc :Lemaitre q1 2017 record sales $24.1 mm (+19%), net income $3.2 mm (+49%).Q1 earnings per share $0.16.Qtrly sales of $24.1 million up 19% versus. Q1 2016.Lemaitre Vascular Inc sees q2 sales $25.4 million; sees q2 earnings per share $0.17.Lemaitre Vascular Inc sees fy 2017 sales $100.5 million; sees q2 earnings per share $0.70.Q1 earnings per share view $0.13, revenue view $23.5 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.17, revenue view $25.0 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $0.66, revenue view $99.0 million -- Thomson Reuters I/B/E/S.  Full Article

Lemaitre Vascular Q4 earnings per share $0.13
Tuesday, 21 Feb 2017 04:05pm EST 

Lemaitre Vascular Inc : Q4 earnings per share $0.13 . Q4 earnings per share view $0.15 -- Thomson Reuters I/B/E/S . Qtrly sales of $23.3 million, up 14% versus. Q4 2015 .Sees Q1 sales of $23.5 million, sees 2017 sales of $99.0 million.  Full Article

Lemaitre Vascular Q3 EPS $0.17
Wednesday, 26 Oct 2016 04:05pm EDT 

Lemaitre Vascular Inc : Q3 earnings per share $0.17 . Q3 earnings per share view $0.15 -- Thomson Reuters I/B/E/S . Qtrly sales of $23.2 million, up 22 pct versus. Q3 2015 . Sees 2016 sales $89.0 million (+14 pct reported, +12 pct organic) . FY2016 revenue view $88.3 million -- Thomson Reuters I/B/E/S .Q3 revenue view $22.2 million -- Thomson Reuters I/B/E/S.  Full Article

Lemaitre Vascular says Q2 earnings per share $0.14
Wednesday, 27 Jul 2016 04:05pm EDT 

Lemaitre Vascular Inc : Lemaitre q2 2016 record sales $22.4mm (+13%), record op. Income $3.8mm (+35%) . Q2 earnings per share $0.14 . Q2 earnings per share view $0.11 -- Thomson Reuters I/B/E/S .Lemaitre vascular inc qtrly sales of $22.4 million, up 13 percent.  Full Article

LeMaitre Vascular, Inc gives Q2 2016 guidance; raises FY 2016 guidance
Monday, 2 May 2016 04:05pm EDT 

LeMaitre Vascular, Inc:Expects Q2 2016 sales of $21.6 mln, a reported increase of 9% vs. Q2 2015.expects Q2 2016 gross margin of 69.0%.expects Q2 2016 operating income of $3.2 mln (15% operating margin), an increase of 15% vs. Q2 2015.Increased FY 2016 sales guidance to $85.7 mln, a reported increase of 9% vs. 2015.expects FY 2016 gross margin of 70.5%.increased FY 2016 operating income guidance to $14.3 mln (17% operating margin), a 24% increase vs. 2015.  Full Article

LeMaitre Vascular acquires ProCol Vascular Bioprosthesis
Friday, 18 Mar 2016 02:30pm EDT 

LeMaitre Vascular:Has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories Inc for $665,000 plus a three year royalty.In conjunction with the acquisition, Hancock Jaffe Laboratories will provide manufacturing transition services to LeMaitre Vascular from its production facility in Irvine, CA for up to five years.  Full Article

BRIEF-Lemaitre Vascular sees ‍Q4 sales of $25.8 mln

* Lemaitre Vascular Inc - qtrly ‍sales of $24.8 million, up 7% from Q3 2016​